Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Cancer Immunology Research|June 7, 2014
Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockadeZachary A Cooper, Vikram R Juneja, Peter T Sage, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
BRAFV600E-Driven Lung Tumorigenesis Requires Ligand-Mediated Activation of ERBB Receptor SignalingMelanie Angelina Dacheux, Meng-Jung Wu, Michael T Scherzer, et al.
Pigment Cell & Melanoma Research|August 8, 2009
Meeting report: consensus from the first and second Global Workshops in Melanoma November 19-20, 2008Sanjiv S Agarwala, Jurgen C Becker, Alexander M Eggermont, et al.
Cell Reports|March 21, 2026
Identification and characterization of BRAF⇔TP53 interactions in melanomaKayla T O'Toole, Adamaris Martinez, Brandon Murphy, et al.
Melanoma Research|August 12, 2017
Risk factors for development of melanoma brain metastasis and disease progression: a single-center retrospective analysisLaura J Gardner, Morgan Ward, Robert H I Andtbacka, et al.
Molecular Cancer Research : MCR|May 30, 2019
AKT1E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain MetastasisDavid A Kircher, Kirby A Trombetti, Mark R Silvis, et al.
Oncogene|April 28, 2026
Rapid activation of ARF6 after RAF inhibition augments BRAFV600E and promotes therapy resistanceJunhua Wang, Yinshen Wee, Thomas Jacob, et al.
Cell Reports|April 22, 2014
Isolation and molecular characterization of circulating melanoma cellsXi Luo, Devarati Mitra, Ryan J Sullivan, et al.
Nature|November 6, 2012
An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin backgroundDevarati Mitra, Xi Luo, Ann Morgan, et al.
Cancer Research|September 16, 2022
Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung TumorigenesisAria Vaishnavi, Joseph Juan, Maebh Jacob, et al.
Pageof 13